Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • A study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.

    Recruiting

    2 1 1
    Italy The Netherlands Spain
  • Study of SAT-3247 Compared to Placebo for Patients with Duchenne Muscular Dystrophy Who Can Walk

    Recruiting

    2 1
    Investigated Drugs:
    Belgium Poland Spain
  • Study of ENTR-601-45 Safety and Effectiveness in Patients with Duchenne Muscular Dystrophy Who Can Skip Exon 45

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Italy The Netherlands Spain
  • Study of ENTR-601-44 in Children with Duchenne Muscular Dystrophy Who Are Eligible for Exon 44 Skipping Treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Italy Spain
  • Study of SGT-003 Gene Therapy for Safety and Tolerability in Walking Males with Duchenne Muscular Dystrophy

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Long-Term Safety and Efficacy Study of Givinostat for Patients with Duchenne Muscular Dystrophy Previously Treated with Givinostat

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy The Netherlands Spain
  • Study on the Safety and Effects of Givinostat in Young Children with Duchenne Muscular Dystrophy (Ages 2 to Less Than 6 Years)

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Italy The Netherlands
  • Long-term Safety Study of Delandistrogene Moxeparvovec for Patients with Duchenne Muscular Dystrophy Who Previously Received SRP-9001

    Recruiting

    3 1 1
    Investigated Drugs:
    Belgium Germany Italy Spain
  • Efficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Italy The Netherlands +3
  • Study on the Safety and Effects of SQY51 for Children and Adults with Duchenne Muscular Dystrophy

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France